Join to View Full Profile
Brigham and Womans Hospital Immunogenetics Transplant75 Francis St PBB Adm 1Boston, MA 02115
Phone+1 617-732-5868
Dr. Najafian is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Education & Training
Mass General Brigham/Brigham and Women's Hospital/Massachusetts General HospitalFellowship, Nephrology, 1998 - 2002
University of Iowa Hospitals and ClinicsResidency, Internal Medicine, 1995 - 1998
University of Vienna Faculty of MedicineClass of 1995
Certifications & Licensure
FL State Medical License 2013 - 2027
MA State Medical License 1997 - 2026
CA State Medical License 1997 - 2025
IA State Medical License 1995 - 2002
American Board of Internal Medicine Nephrology
Clinical Trials
- Characterization of Immunological Profile of Renal Transplant Patients Undergoing Induction Treatment With Thymoglobulin vs. IL-2 Receptor Antagonist Basiliximab Start of enrollment: 2008 Sep 01
- A Study of an Investigational Drug, Cemdisiran (ALN-CC5), in Patients With Atypical Hemolytic Uremic Syndrome Start of enrollment: 2017 Sep 19
- A Study to Investigate the Interaction Between Givosiran and a 5-probe Drug Cocktail in Patients With Acute Intermittent Porphyria (AIP) Start of enrollment: 2018 Apr 26
- Join now to see all
Publications & Presentations
PubMed
- 4 citationsAdvancing mouse models for transplantation research.Paolo Cravedi, Leonardo V Riella, Mandy L Ford, Anna Valujskikh, Madhav C Menon
American Journal of Transplantation. 2024-08-01 - 26 citationsClinical Outcomes of Patients with C3G or IC-MPGN Treated with the Factor D Inhibitor Danicopan: Final Results from Two Phase 2 Studies.Carla Nester, Gerald B Appel, Andrew S Bomback, Koenraad Peter Bouman, H Terence Cook
American Journal of Nephrology. 2022-01-01 - 21 citationsA Drug-Drug Interaction Study Evaluating the Effect of Givosiran, a Small Interfering Ribonucleic Acid, on Cytochrome P450 Activity in the Liver.Daphne Vassiliou, Eliane Sardh, Pauline Harper, Amy Simon, Valerie A. Clausen
Clinical Pharmacology and Therapeutics. 2021-11-01
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
